Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties

doi:10.1084/jem.169.5.1721

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Andrews, R. G.
	Articles by Bernstein, I. D.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Andrews, R. G.
	Articles by Bernstein, I. D.


Social Bookmarking

	What's this?

ARTICLES

Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties

RG Andrews, JW Singer and ID Bernstein
Pediatric Oncology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.

We determined whether human marrow cells that directly form colonies in vitro could be distinguished from cells that generate or become CFC only after LTMC in the presence of irradiated marrow stromal cells. In previous studies, an anti-CD33 antibody, L4F3, and complement (C') were used to lyse nearly all CFC in marrow, and the remaining cells generated CFC in LTMC. In the present studies, marrow cells were treated with L4F3 + C' and the remaining CD33- cells were separated into CD34+ and CD34- populations and placed in LTMC. Only the CD34+ cells were found to generate significant numbers of CFC. To compare the CD33-CD34+ and CD33+CD34+ cells, we isolated each cell population using two-color FACS. Only LTMCs of the CD33-CD34+ cells generated CFC for greater than 5 wk. In contrast, cells that expressed both the CD33 and CD34 antigens, which contained most of the CFC, generated few CFC in LTMC. Fractionation of marrow cells based on right angle and forward light scattering suggested that precursors for CFC have low right angle and low forward light scattering properties. The CD33-CD34+ marrow cells were therefore further fractionated based on light scatter characteristics. Cells with low right angle and low forward light scatter formed few or no colonies on direct culture, yet generated greater numbers of CFC after 4 wk of LTMC than did cells with low right angle and high forward light scatter. Most (87-98%) CFC generated in the LTMCs that were initiated with CD33-CD34+ cells were found to express the CD33 antigen. Thus, hematopoietic progenitors with differing proliferative and differentiative potentials can be directly separated on the basis of their expression of CD33 and CD34 cell surface antigens and their light scatter properties.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Daniels, T. R., Ng, P. P., Delgado, T., Lynch, M. R., Schiller, G., Helguera, G., Penichet, M. L. (2007). Conjugation of an anti transferrin receptor IgG3-avidin fusion protein with biotinylated saporin results in significant enhancement of its cytotoxicity against malignant hematopoietic cells. Molecular Cancer Therapeutics 6: 2995-3008 [Abstract] [Full Text]
Buitenhuis, M., Verhagen, L. P., Cools, J., Coffer, P. J. (2007). Molecular Mechanisms Underlying FIP1L1-PDGFRA-Mediated Myeloproliferation. Cancer Res. 67: 3759-3766 [Abstract] [Full Text]
Matmati, M., Pouwels, W., van Bruggen, R., Jansen, M., Hoek, R. M., Verhoeven, A. J., Hamann, J. (2007). The human EGF-TM7 receptor EMR3 is a marker for mature granulocytes. J. Leukoc. Biol. 81: 440-448 [Abstract] [Full Text]
Pollard, J. A., Alonzo, T. A., Gerbing, R. B., Woods, W. G., Lange, B. J., Sweetser, D. A., Radich, J. P., Bernstein, I. D., Meshinchi, S. (2006). FLT3 internal tandem duplication in CD34+/CD33- precursors predicts poor outcome in acute myeloid leukemia. Blood 108: 2764-2769 [Abstract] [Full Text]
Taussig, D. C., Pearce, D. J., Simpson, C., Rohatiner, A. Z., Lister, T. A., Kelly, G., Luongo, J. L., Danet-Desnoyers, G.-a. H., Bonnet, D. (2005). Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia. Blood 106: 4086-4092 [Abstract] [Full Text]
Fang, B., Zheng, C., Liao, L., Han, Q., Sun, Z., Jiang, X., Zhao, R. C. H. (2005). Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics. Blood 105: 2733-2740 [Abstract] [Full Text]
Christiansen, J., Rajasekaran, A. K. (2004). Biological impediments to monoclonal antibody-based cancer immunotherapy. Molecular Cancer Therapeutics 3: 1493-1501 [Abstract] [Full Text]
Shields, L. E., Gaur, L., Delio, P., Potter, J., Sieverkropp, A., Andrews, R. G. (2004). Fetal Immune Suppression as Adjunctive Therapy for In Utero Hematopoietic Stem Cell Transplantation in Nonhuman Primates. Stem Cells 22: 759-769 [Abstract] [Full Text]
Walter, R. B., Raden, B. W., Cronk, M. R., Bernstein, I. D., Appelbaum, F. R., Banker, D. E. (2004). The peripheral benzodiazepine receptor ligand PK11195 overcomes different resistance mechanisms to sensitize AML cells to gemtuzumab ozogamicin. Blood 103: 4276-4284 [Abstract] [Full Text]
DiJoseph, J. F., Armellino, D. C., Boghaert, E. R., Khandke, K., Dougher, M. M., Sridharan, L., Kunz, A., Hamann, P. R., Gorovits, B., Udata, C., Moran, J. K., Popplewell, A. G., Stephens, S., Frost, P., Damle, N. K. (2004). Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies. Blood 103: 1807-1814 [Abstract] [Full Text]
Walter, R. B., Raden, B. W., Hong, T. C., Flowers, D. A., Bernstein, I. D., Linenberger, M. L. (2003). Multidrug resistance protein attenuates gemtuzumab ozogamicin-induced cytotoxicity in acute myeloid leukemia cells. Blood 102: 1466-1473 [Abstract] [Full Text]
Shields, L. E., Gaur, L. K., Gough, M., Potter, J., Sieverkropp, A., Andrews, R. G. (2003). In Utero Hematopoietic Stem Cell Transplantation in Nonhuman Primates: The Role of T Cells. Stem Cells 21: 304-314 [Abstract] [Full Text]
Kawaguchi, H., Kobayashi, M., Nakamura, K., Konishi, N., Miyagawa, S.-i., Sato, T., Toyoda, H., Komada, Y., Kojima, S., Todoroki, Y., Ueda, K., Katoh, O. (2003). Dysregulation of transcriptions in primary granule constituents during myeloid proliferation and differentiation in patients with severe congenital neutropenia. J. Leukoc. Biol. 73: 225-234 [Abstract] [Full Text]
Countouriotis, A., Moore, T. B., Sakamoto, K. M. (2002). Cell Surface Antigen and Molecular Targeting in the Treatment of Hematologic Malignancies. Stem Cells 20: 215-229 [Abstract] [Full Text]
Barosi, G., Viarengo, G., Pecci, A., Rosti, V., Piaggio, G., Marchetti, M., Frassoni, F. (2001). Diagnostic and clinical relevance of the number of circulating CD34+ cells in myelofibrosis with myeloid metaplasia. Blood 98: 3249-3255 [Abstract] [Full Text]
Aprikyan, A. A. G., Liles, W. C., Park, J. R., Jonas, M., Chi, E. Y., Dale, D. C. (2000). Myelokathexis, a congenital disorder of severe neutropenia characterized by accelerated apoptosis and defective expression of bcl-x in neutrophil precursors. Blood 95: 320-327 [Abstract] [Full Text]
Vitale, C., Romagnani, C., Falco, M., Ponte, M., Vitale, M., Moretta, A., Bacigalupo, A., Moretta, L., Mingari, M. C. (1999). Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells. Proc. Natl. Acad. Sci. USA 96: 15091-15096 [Abstract] [Full Text]
Ramsfjell, V., Bryder, D., Bjorgvinsdottir, H., Kornfalt, S., Nilsson, L., Borge, O. J., Jacobsen, S. E.W. (1999). Distinct Requirements for Optimal Growth and In Vitro Expansion of Human CD34+CD38- Bone Marrow Long-Term Culture-Initiating Cells (LTC-IC), Extended LTC-IC, and Murine In Vivo Long-Term Reconstituting Stem Cells. Blood 94: 4093-4102 [Abstract] [Full Text]
Sievers, E.L., Appelbaum, F.R., Spielberger, R.T., Forman, S.J., Flowers, D., Smith, F.O., Shannon-Dorcy, K., Berger, M.S., Bernstein, I.D. (1999). Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin Immunoconjugate. Blood 93: 3678-3684 [Abstract] [Full Text]
Blair, A., Hogge, D.E., Sutherland, H.J. (1998). Most Acute Myeloid Leukemia Progenitor Cells With Long-Term Proliferative Ability In Vitro and In Vivo Have the Phenotype CD34+/CD71-/HLA-DR-. Blood 92: 4325-4335 [Abstract] [Full Text]
Zannettino, A. C.W., Buhring, H.-J., Niutta, S., Watt, S. M., Benton, M. A., Simmons, P. J. (1998). The Sialomucin CD164 (MGC-24v) Is an Adhesive Glycoprotein Expressed by Human Hematopoietic Progenitors and Bone Marrow Stromal Cells That Serves as a Potent Negative Regulator of Hematopoiesis. Blood 92: 2613-2628 [Abstract] [Full Text]
Opie, T. M., Shields, L. E., Andrews, R. G. (1998). Cell-Surface Antigen Expression in Early and Term Gestation Fetal Hematopoietic Progenitor Cells. Stem Cells 16: 343-348 [Abstract] [Full Text]
Fukuda, J., Kaneko, T., Egashira, M., Oshimi, K. (1998). Direct Measurement of CD34+ Blood Stem Cell Absolute Counts by Flow Cytometry. Stem Cells 16: 294-300 [Abstract] [Full Text]
Koller, M. R., Manchel, I., Smith, A. K. (1998). Quantitative Long-Term Culture-Initiating Cell Assays Require Accessory Cell Depletion That Can Be Achieved by CD34-Enrichment or 5-Fluorouracil Exposure. Blood 91: 4056-4064 [Abstract] [Full Text]
Ryncarz, R. E., Anasetti, C. (1998). Expression of CD86 on Human Marrow CD34+ Cells Identifies Immunocompetent Committed Precursors of Macrophages and Dendritic Cells. Blood 91: 3892-3900 [Abstract] [Full Text]
Hahn, G., Jores, R., Mocarski, E. S. (1998). Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl. Acad. Sci. USA 95: 3937-3942 [Abstract] [Full Text]
Lewis, I. D., McDiarmid, L. A., Samels, L. M., Bik To, L., Hughes, T. P. (1998). Establishment of a Reproducible Model of Chronic-Phase Chronic Myeloid Leukemia in NOD/SCID Mice Using Blood-Derived Mononuclear or CD34+ Cells. Blood 91: 630-640 [Abstract] [Full Text]
Dooley, D. C., Xiao, M., Oppenlander, B. K., Plunkett, J. M., Lyman, S. D. (1997). Flt3 Ligand Enhances the Yield of Primitive Cells After Ex Vivo Cultivation of CD34+ CD38dim Cells and CD34+ CD38dim CD33dim HLA-DR+ Cells. Blood 90: 3903-3913 [Abstract] [Full Text]
Haylock, D. N., Horsfall, M. J., Dowse, T. L., Ramshaw, H. S., Niutta, S., Protopsaltis, S., Peng, L., Burrell, C., Rappold, I., Buhring, H.-J., Simmons, P. J. (1997). Increased Recruitment of Hematopoietic Progenitor Cells Underlies the Ex Vivo Expansion Potential of FLT3 Ligand. Blood 90: 2260-2272 [Abstract] [Full Text]
de Jong, M. O., Westerman, Y., Wagemaker, G., Wognum, A. W. (1997). Coexpression of Kit and the Receptors for Erythropoietin, Interleukin 6 and GM-CSF on Hemopoietic Cells. Stem Cells 15: 275-285 [Abstract] [Full Text]
Blair, A., Hogge, D.E., Ailles, L.E., Lansdorp, P.M., Sutherland, H.J. (1997). Lack of Expression of Thy-1 (CD90) on Acute Myeloid Leukemia Cells With Long-Term Proliferative Ability In Vitro and In Vivo. Blood 89: 3104-3112 [Abstract] [Full Text]
To, L.B., Haylock, D.N., Simmons, P.J., Juttner, C.A. (1997). The Biology and Clinical Uses of Blood Stem Cells. Blood 89: 2233-2258 [Full Text]
Muench, M. O., Roncarolo, M. G., Namikawa, R. (1997). Phenotypic and Functional Evidence for the Expression of CD4 by Hematopoietic Stem Cells Isolated From Human Fetal Liver. Blood 89: 1364-1375 [Abstract] [Full Text]
Aiuti, A., Webb, I.J., Bleul, C., Springer, T., Gutierrez-Ramos, J.C. (1997). The Chemokine SDF-1 Is a Chemoattractant for Human CD34+ Hematopoietic Progenitor Cells and Provides a New Mechanism to Explain the Mobilization of CD34+ Progenitors to Peripheral Blood. J. Exp. Med. 185: 111-120 [Abstract] [Full Text]
Andrews, R., Winkler, A, Myerson, D, Briddell, R., Knitter, G., McNiece, I., Hunt, P (1996). Recombinant human ligand for MPL, megakaryocyte growth and development factor (MGDF), stimulates thrombopoiesis in vivo in normal and myelosuppressed baboons. Stem Cells 14: 661-677 [Abstract]
Freedman, M., Hitzler, J., Bunin, N, Grunberger, T, Squire, J (1996). Juvenile chronic myelogenous leukemia multilineage CD34+ cells: aberrant growth and differentiation properties. Stem Cells 14: 690-701 [Abstract]
Gabbianelli, M, Sargiacomo, M, Pelosi, E, Testa, U, Isacchi, G, Peschle, C (1990). "Pure" human hematopoietic progenitors: permissive action of basic fibroblast growth factor. Science 249: 1561-1564 [Abstract]